British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development center in Beijing, China.

Over 50 percent of the space will be dedicated to cultural and artistic experiences, with 60 percent of the brands debuting in the sub city-center. Beijing Hops On, formerly a traditional mall in ...

The Beijing City Library is a landmark in Beijing's newly established sub-center. "It boasts the world's largest climatised reading space and China's largest load-bearing glass system, leveraging ...

The investment in Beijing comes as part of a partnership with the city's Municipal Government ... as the company already has a research and development center in Shanghai. The Beijing center ...